We have recently partnered with Pace Dermatology to bring more accessible and innovative dermatology treatments to patients in the South Sound and Pacific Northwest. Together, patients benefit from the research expertise of the MultiCare’s Institute for Research & Innovation and the highly-skilled, passionate clinical team at Pace Dermatology.
Dermatology studies include, but are not limited to, the following therapeutic areas:
Drs. Aaron and Andrew Pace lead Pace Dermatology – with locations in Tacoma and Lakewood. They are board certified in dermatology, so patients can expect the highest level of care.
Please click here to learn more about Pace Dermatology.
Study Number: CAIN457A2323 – a multicenter, randomized, double-blind, placebo-controlled, 52-week study to demonstrate the efficacy, safety, and tolerability of subcutaneous Secukinumab injections with 2mL pre-filled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis—ALLURE.
Principal Investigator: Andrew Pace, MD
Study Coordinator: Shannon Harris, [email protected], 253-301-6992